ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to beat back relapsed leukemia
Disease control Recruiting nowThis study tests a new chemotherapy drug, L-Annamycin, combined with standard cytarabine in adults with acute myeloid leukemia (AML) that has come back or not responded to first treatment. About 312 participants will receive either the new drug combo or a placebo plus cytarabine.…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2, PHASE3 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cocktail aims to snuff out residual AML before it returns
Disease control Recruiting nowThis study tests a combination of three drugs—tagraxofusp, azacitidine, and venetoclax—in adults with acute myeloid leukemia (AML) who are in remission but still have tiny amounts of cancer cells that standard tests miss. The goal is to see if the combo can safely clear these hid…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo aims to keep leukemia at bay after remission
Disease control Recruiting nowThis study tests whether a combination of two drugs (venetoclax and low-dose cytarabine) can help adults with acute myeloid leukemia (AML) stay in remission longer. Participants are 18–60 years old, have achieved complete remission after initial chemotherapy, and are not able to …
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Scientists hunt for clues in blood cancer samples to improve future treatments
Knowledge-focused Recruiting nowThis study is collecting blood, bone marrow, and leftover tissue samples from 550 people with acute myeloid leukemia or follicular lymphoma. Researchers will analyze the samples to find genetic markers that may predict how well treatments work or why some stop working. The goal i…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC